

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of skin barrier (GO:0061436) | 6.70826959 |
| 2 | regulation of water loss via skin (GO:0033561) | 6.53153464 |
| 3 | keratinocyte proliferation (GO:0043616) | 6.06839520 |
| 4 | cell-substrate junction assembly (GO:0007044) | 6.00275177 |
| 5 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.24940803 |
| 6 | surfactant homeostasis (GO:0043129) | 5.20916492 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.09208098 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.09208098 |
| 9 | multicellular organismal water homeostasis (GO:0050891) | 5.06047785 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.02965743 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.02965743 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 4.97136717 |
| 13 | keratinization (GO:0031424) | 4.89242429 |
| 14 | hemidesmosome assembly (GO:0031581) | 4.84518981 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.77334377 |
| 16 | protein carboxylation (GO:0018214) | 4.75758109 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.75758109 |
| 18 | desmosome organization (GO:0002934) | 4.69734218 |
| 19 | gap junction assembly (GO:0016264) | 4.64485845 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.55334302 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 4.52578246 |
| 22 | urea cycle (GO:0000050) | 4.52021530 |
| 23 | urea metabolic process (GO:0019627) | 4.52021530 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 4.45705774 |
| 25 | cell adhesion mediated by integrin (GO:0033627) | 4.39775140 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.29334437 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.27802283 |
| 28 | fibrinolysis (GO:0042730) | 4.24651795 |
| 29 | intermediate filament organization (GO:0045109) | 4.24463798 |
| 30 | kynurenine metabolic process (GO:0070189) | 4.19208837 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 4.15824753 |
| 32 | water homeostasis (GO:0030104) | 4.15775273 |
| 33 | bile acid biosynthetic process (GO:0006699) | 4.15471065 |
| 34 | chemical homeostasis within a tissue (GO:0048875) | 4.14998571 |
| 35 | cysteine metabolic process (GO:0006534) | 4.13438336 |
| 36 | glyoxylate metabolic process (GO:0046487) | 4.10881391 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.06942861 |
| 38 | indole-containing compound catabolic process (GO:0042436) | 4.06469955 |
| 39 | indolalkylamine catabolic process (GO:0046218) | 4.06469955 |
| 40 | tryptophan catabolic process (GO:0006569) | 4.06469955 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.04168047 |
| 42 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 4.03894964 |
| 43 | regulation of complement activation (GO:0030449) | 4.03524816 |
| 44 | epidermis development (GO:0008544) | 3.96506905 |
| 45 | tryptophan metabolic process (GO:0006568) | 3.86119789 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 3.85642349 |
| 47 | regulation of keratinocyte proliferation (GO:0010837) | 3.85367908 |
| 48 | reverse cholesterol transport (GO:0043691) | 3.83976678 |
| 49 | keratinocyte differentiation (GO:0030216) | 3.83077189 |
| 50 | phospholipid efflux (GO:0033700) | 3.81747719 |
| 51 | regulation of triglyceride catabolic process (GO:0010896) | 3.72272565 |
| 52 | homocysteine metabolic process (GO:0050667) | 3.68631310 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 3.65147981 |
| 54 | negative regulation of sterol transport (GO:0032372) | 3.65147981 |
| 55 | gonadal mesoderm development (GO:0007506) | 3.63915595 |
| 56 | protein localization to endosome (GO:0036010) | 3.62646359 |
| 57 | bile acid metabolic process (GO:0008206) | 3.60409448 |
| 58 | cellular glucuronidation (GO:0052695) | 3.60212769 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 3.60149335 |
| 60 | plasma lipoprotein particle remodeling (GO:0034369) | 3.58544741 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 3.58544741 |
| 62 | macromolecular complex remodeling (GO:0034367) | 3.58544741 |
| 63 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.58504284 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 3.56828416 |
| 65 | polarized epithelial cell differentiation (GO:0030859) | 3.52974708 |
| 66 | establishment of tissue polarity (GO:0007164) | 3.52969101 |
| 67 | establishment of planar polarity (GO:0001736) | 3.52969101 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.52208644 |
| 69 | COPI coating of Golgi vesicle (GO:0048205) | 3.49662508 |
| 70 | Golgi transport vesicle coating (GO:0048200) | 3.49662508 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.47624493 |
| 72 | positive regulation of epidermis development (GO:0045684) | 3.46328415 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44090473 |
| 74 | endodermal cell differentiation (GO:0035987) | 3.40746393 |
| 75 | acylglycerol homeostasis (GO:0055090) | 3.40112266 |
| 76 | triglyceride homeostasis (GO:0070328) | 3.40112266 |
| 77 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.38324041 |
| 78 | regulation of hair follicle development (GO:0051797) | 3.37770514 |
| 79 | skin morphogenesis (GO:0043589) | 3.37215524 |
| 80 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.36426476 |
| 81 | negative regulation of lipase activity (GO:0060192) | 3.34677230 |
| 82 | cholesterol efflux (GO:0033344) | 3.34169192 |
| 83 | epoxygenase P450 pathway (GO:0019373) | 3.33648516 |
| 84 | bile acid and bile salt transport (GO:0015721) | 3.29217568 |
| 85 | tyrosine metabolic process (GO:0006570) | 3.28466410 |
| 86 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.27121671 |
| 87 | primary alcohol catabolic process (GO:0034310) | 3.25163354 |
| 88 | aromatic amino acid family metabolic process (GO:0009072) | 3.23967115 |
| 89 | keratinocyte development (GO:0003334) | 3.23915063 |
| 90 | glucuronate metabolic process (GO:0019585) | 3.22331126 |
| 91 | uronic acid metabolic process (GO:0006063) | 3.22331126 |
| 92 | ethanol oxidation (GO:0006069) | 3.20554993 |
| 93 | glycine metabolic process (GO:0006544) | 3.19283308 |
| 94 | epithelial cell-cell adhesion (GO:0090136) | 3.18984399 |
| 95 | mesodermal cell differentiation (GO:0048333) | 3.18599437 |
| 96 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.18366123 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 3.15126903 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.14885004 |
| 99 | complement activation (GO:0006956) | 3.13222531 |
| 100 | sterol homeostasis (GO:0055092) | 3.12066813 |
| 101 | lysine metabolic process (GO:0006553) | 3.11348981 |
| 102 | lysine catabolic process (GO:0006554) | 3.11348981 |
| 103 | response to nitrosative stress (GO:0051409) | 3.11062402 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.10854689 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.10517865 |
| 106 | benzene-containing compound metabolic process (GO:0042537) | 3.10446671 |
| 107 | acute-phase response (GO:0006953) | 3.08422167 |
| 108 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.06687416 |
| 109 | regulation of plasminogen activation (GO:0010755) | 3.05202014 |
| 110 | midgut development (GO:0007494) | 3.04926741 |
| 111 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.04864149 |
| 112 | aldehyde catabolic process (GO:0046185) | 3.04088341 |
| 113 | imidazole-containing compound metabolic process (GO:0052803) | 3.03784422 |
| 114 | ethanol metabolic process (GO:0006067) | 3.03050967 |
| 115 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.02712958 |
| 116 | protein-lipid complex assembly (GO:0065005) | 3.02011129 |
| 117 | protein activation cascade (GO:0072376) | 3.01420900 |
| 118 | arginine metabolic process (GO:0006525) | 3.00473912 |
| 119 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.00013743 |
| 120 | epidermal cell differentiation (GO:0009913) | 2.98986974 |
| 121 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.98742835 |
| 122 | alpha-amino acid catabolic process (GO:1901606) | 2.97049905 |
| 123 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.97023275 |
| 124 | cellular modified amino acid catabolic process (GO:0042219) | 2.96882311 |
| 125 | 4-hydroxyproline metabolic process (GO:0019471) | 2.95446660 |
| 126 | peptide cross-linking (GO:0018149) | 2.95085624 |
| 127 | low-density lipoprotein particle clearance (GO:0034383) | 2.95066168 |
| 128 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.95038781 |
| 129 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.95038781 |
| 130 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.93338259 |
| 131 | negative regulation of blood coagulation (GO:0030195) | 2.92783429 |
| 132 | negative regulation of hemostasis (GO:1900047) | 2.92783429 |
| 133 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.92753620 |
| 134 | serine family amino acid metabolic process (GO:0009069) | 2.92641900 |
| 135 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.92155441 |
| 136 | phospholipid homeostasis (GO:0055091) | 2.89066223 |
| 137 | * lipoprotein metabolic process (GO:0042157) | 2.86597480 |
| 138 | hair cycle (GO:0042633) | 2.86320593 |
| 139 | molting cycle (GO:0042303) | 2.86320593 |
| 140 | positive regulation of hemostasis (GO:1900048) | 2.84689270 |
| 141 | positive regulation of blood coagulation (GO:0030194) | 2.84689270 |
| 142 | cell junction assembly (GO:0034329) | 2.83609867 |
| 143 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.83071969 |
| 144 | regulation of keratinocyte differentiation (GO:0045616) | 2.82655504 |
| 145 | hypotonic response (GO:0006971) | 2.82363710 |
| 146 | ectoderm development (GO:0007398) | 2.79501951 |
| 147 | renal filtration (GO:0097205) | 2.79469037 |
| 148 | regulation of epidermis development (GO:0045682) | 2.77940260 |
| 149 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.75162437 |
| 150 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.74806331 |
| 151 | protein retention in ER lumen (GO:0006621) | 2.74245594 |
| 152 | focal adhesion assembly (GO:0048041) | 2.74166316 |
| 153 | cell-substrate adherens junction assembly (GO:0007045) | 2.74166316 |
| 154 | cell junction organization (GO:0034330) | 2.71770372 |
| 155 | positive regulation of hair follicle development (GO:0051798) | 2.71012454 |
| 156 | positive regulation of hair cycle (GO:0042635) | 2.71012454 |
| 157 | exogenous drug catabolic process (GO:0042738) | 2.70691503 |
| 158 | L-serine transport (GO:0015825) | 2.69039911 |
| 159 | atrioventricular valve morphogenesis (GO:0003181) | 2.68715409 |
| 160 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.66846072 |
| 161 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.66775382 |
| 162 | intermediate filament cytoskeleton organization (GO:0045104) | 2.64861974 |
| 163 | semaphorin-plexin signaling pathway (GO:0071526) | 2.64649371 |
| 164 | intestinal epithelial cell development (GO:0060576) | 2.63870681 |
| 165 | adherens junction assembly (GO:0034333) | 2.58662392 |
| 166 | skin development (GO:0043588) | 2.54863833 |
| 167 | intermediate filament-based process (GO:0045103) | 2.52474859 |
| 168 | basement membrane organization (GO:0071711) | 2.52420320 |
| 169 | drug catabolic process (GO:0042737) | 2.51846429 |
| 170 | intestinal cholesterol absorption (GO:0030299) | 2.51593488 |
| 171 | proline metabolic process (GO:0006560) | 2.50626500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.50222388 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.51297945 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.36160631 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.83513707 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.53328288 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.22814798 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.01254253 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.94868273 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.10230630 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.96076315 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.94183393 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.81959359 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.66921456 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.62431505 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.10348451 |
| 16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.09125475 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.02203903 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99647134 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.90794759 |
| 20 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.88357033 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.81913877 |
| 22 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77318056 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75484697 |
| 24 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66974287 |
| 25 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.64949739 |
| 26 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.64949739 |
| 27 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.64683245 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62678159 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61063321 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60537153 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60292006 |
| 32 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.56850145 |
| 33 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53915553 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53176141 |
| 35 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.49904700 |
| 36 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.49837830 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48931575 |
| 38 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47571436 |
| 39 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.45864410 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44013416 |
| 41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40852036 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39052395 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.38792834 |
| 44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34886648 |
| 45 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31979461 |
| 46 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.31596241 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27200107 |
| 48 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.26562040 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.24502606 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24463370 |
| 51 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22549573 |
| 52 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.22444414 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22404972 |
| 54 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20534196 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19141045 |
| 56 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18256468 |
| 57 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.10438473 |
| 58 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10206819 |
| 59 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09861788 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08762536 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08646209 |
| 62 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.06183238 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05909650 |
| 64 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.02968291 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02394327 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01745928 |
| 67 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99952322 |
| 68 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99952322 |
| 69 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98875310 |
| 70 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98617688 |
| 71 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.98490860 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96689850 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93707394 |
| 74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92345684 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91488321 |
| 76 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91209442 |
| 77 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.90424885 |
| 78 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89735733 |
| 79 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.89359025 |
| 80 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88167558 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87470471 |
| 82 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86694078 |
| 83 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85906208 |
| 84 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85605551 |
| 85 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85544922 |
| 86 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85202928 |
| 87 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84425749 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84251580 |
| 89 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.84009755 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83324830 |
| 91 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.83289538 |
| 92 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82906363 |
| 93 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.81954204 |
| 94 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80778830 |
| 95 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80778830 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80578035 |
| 97 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80406164 |
| 98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80318768 |
| 99 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79955762 |
| 100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.79718891 |
| 101 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79322983 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78931170 |
| 103 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.78308798 |
| 104 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77371093 |
| 105 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.77008773 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.76621188 |
| 107 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76578358 |
| 108 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.76570407 |
| 109 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.76546083 |
| 110 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.76351527 |
| 111 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.75957917 |
| 112 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.75310369 |
| 113 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75026847 |
| 114 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.74595647 |
| 115 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74026092 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73894161 |
| 117 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.72535713 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72492811 |
| 119 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.71203079 |
| 120 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.71117062 |
| 121 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.70498092 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.69104870 |
| 123 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68436628 |
| 124 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.68191266 |
| 125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.66883828 |
| 126 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.65296937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.88871564 |
| 2 | MP0005360_urolithiasis | 4.44732734 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.87789273 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.82091406 |
| 5 | MP0005365_abnormal_bile_salt | 3.52498946 |
| 6 | MP0005275_abnormal_skin_tensile | 3.16670447 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.16334504 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.06719106 |
| 9 | MP0002796_impaired_skin_barrier | 2.88161451 |
| 10 | MP0003252_abnormal_bile_duct | 2.46066231 |
| 11 | MP0005083_abnormal_biliary_tract | 2.42603929 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.39201868 |
| 13 | MP0005409_darkened_coat_color | 2.38190877 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.36394106 |
| 15 | MP0009840_abnormal_foam_cell | 2.31314395 |
| 16 | MP0002060_abnormal_skin_morphology | 2.26466539 |
| 17 | MP0002254_reproductive_system_inflammat | 2.21328834 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.19366296 |
| 19 | MP0000579_abnormal_nail_morphology | 2.16428625 |
| 20 | MP0003453_abnormal_keratinocyte_physiol | 1.96583139 |
| 21 | MP0009053_abnormal_anal_canal | 1.93838471 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.92819852 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.91660007 |
| 24 | MP0005501_abnormal_skin_physiology | 1.80815264 |
| 25 | MP0003566_abnormal_cell_adhesion | 1.78544005 |
| 26 | MP0003195_calcinosis | 1.70639246 |
| 27 | MP0002098_abnormal_vibrissa_morphology | 1.67252578 |
| 28 | MP0001216_abnormal_epidermal_layer | 1.60482592 |
| 29 | MP0010678_abnormal_skin_adnexa | 1.58831971 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.55043570 |
| 31 | MP0004782_abnormal_surfactant_physiolog | 1.50849382 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.50047947 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.46580207 |
| 34 | MP0000383_abnormal_hair_follicle | 1.44369118 |
| 35 | MP0004272_abnormal_basement_membrane | 1.41216944 |
| 36 | MP0009384_cardiac_valve_regurgitation | 1.40624507 |
| 37 | * MP0005023_abnormal_wound_healing | 1.40023141 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.39154894 |
| 39 | MP0000609_abnormal_liver_physiology | 1.36844920 |
| 40 | MP0000647_abnormal_sebaceous_gland | 1.35149405 |
| 41 | MP0000377_abnormal_hair_follicle | 1.35008270 |
| 42 | MP0004947_skin_inflammation | 1.33751439 |
| 43 | MP0005332_abnormal_amino_acid | 1.33666887 |
| 44 | MP0000467_abnormal_esophagus_morphology | 1.30189024 |
| 45 | MP0000537_abnormal_urethra_morphology | 1.26815645 |
| 46 | MP0008260_abnormal_autophagy | 1.26706256 |
| 47 | MP0010771_integument_phenotype | 1.25627822 |
| 48 | MP0001243_abnormal_dermal_layer | 1.23021501 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.22760936 |
| 50 | MP0006054_spinal_hemorrhage | 1.21273510 |
| 51 | MP0000427_abnormal_hair_cycle | 1.19083794 |
| 52 | MP0003941_abnormal_skin_development | 1.17825920 |
| 53 | MP0001849_ear_inflammation | 1.16296849 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.15426795 |
| 55 | MP0000566_synostosis | 1.12822056 |
| 56 | MP0003315_abnormal_perineum_morphology | 1.10383145 |
| 57 | MP0003011_delayed_dark_adaptation | 1.10120040 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.10095276 |
| 59 | MP0005451_abnormal_body_composition | 1.08723863 |
| 60 | MP0001958_emphysema | 1.08070117 |
| 61 | MP0010030_abnormal_orbit_morphology | 1.06880395 |
| 62 | MP0002089_abnormal_postnatal_growth/wei | 1.05211204 |
| 63 | MP0000762_abnormal_tongue_morphology | 1.04869096 |
| 64 | MP0005319_abnormal_enzyme/_coenzyme | 1.04820293 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.04663561 |
| 66 | MP0000858_altered_metastatic_potential | 1.00042962 |
| 67 | MP0009931_abnormal_skin_appearance | 0.93980542 |
| 68 | MP0004381_abnormal_hair_follicle | 0.91637126 |
| 69 | MP0002282_abnormal_trachea_morphology | 0.89475158 |
| 70 | MP0003186_abnormal_redox_activity | 0.88082904 |
| 71 | MP0002295_abnormal_pulmonary_circulatio | 0.88052909 |
| 72 | MP0003436_decreased_susceptibility_to | 0.86961369 |
| 73 | MP0005248_abnormal_Harderian_gland | 0.86880949 |
| 74 | MP0005503_abnormal_tendon_morphology | 0.85094616 |
| 75 | MP0003950_abnormal_plasma_membrane | 0.85042868 |
| 76 | MP0003279_aneurysm | 0.83856266 |
| 77 | MP0005257_abnormal_intraocular_pressure | 0.83752106 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.81812136 |
| 79 | MP0003868_abnormal_feces_composition | 0.80583232 |
| 80 | MP0001191_abnormal_skin_condition | 0.80223412 |
| 81 | MP0009379_abnormal_foot_pigmentation | 0.77180120 |
| 82 | MP0005408_hypopigmentation | 0.76852421 |
| 83 | MP0009764_decreased_sensitivity_to | 0.76723112 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.76663266 |
| 85 | MP0000598_abnormal_liver_morphology | 0.75908655 |
| 86 | MP0004858_abnormal_nervous_system | 0.73105880 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 0.71508285 |
| 88 | MP0000462_abnormal_digestive_system | 0.71343306 |
| 89 | MP0001661_extended_life_span | 0.70642631 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.68852433 |
| 91 | MP0005076_abnormal_cell_differentiation | 0.68711203 |
| 92 | MP0003755_abnormal_palate_morphology | 0.68280332 |
| 93 | MP0009763_increased_sensitivity_to | 0.65734522 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.65513785 |
| 95 | MP0002234_abnormal_pharynx_morphology | 0.65470377 |
| 96 | MP0008004_abnormal_stomach_pH | 0.64581270 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.64248008 |
| 98 | MP0000538_abnormal_urinary_bladder | 0.63214578 |
| 99 | MP0000367_abnormal_coat/_hair | 0.63106120 |
| 100 | MP0001346_abnormal_lacrimal_gland | 0.62725900 |
| 101 | MP0005647_abnormal_sex_gland | 0.61484308 |
| 102 | MP0001542_abnormal_bone_strength | 0.61298883 |
| 103 | MP0001340_abnormal_eyelid_morphology | 0.60435402 |
| 104 | MP0005508_abnormal_skeleton_morphology | 0.60362610 |
| 105 | MP0005197_abnormal_uvea_morphology | 0.59982333 |
| 106 | MP0002697_abnormal_eye_size | 0.59830886 |
| 107 | * MP0000627_abnormal_mammary_gland | 0.59696940 |
| 108 | MP0009697_abnormal_copulation | 0.59244092 |
| 109 | MP0003091_abnormal_cell_migration | 0.58540614 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58501916 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.58034737 |
| 112 | MP0001533_abnormal_skeleton_physiology | 0.56098105 |
| 113 | MP0002168_other_aberrant_phenotype | 0.55718010 |
| 114 | MP0003115_abnormal_respiratory_system | 0.53968425 |
| 115 | MP0001851_eye_inflammation | 0.53939221 |
| 116 | MP0000604_amyloidosis | 0.53737532 |
| 117 | MP0001881_abnormal_mammary_gland | 0.53650823 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.52610092 |
| 119 | MP0002111_abnormal_tail_morphology | 0.52283235 |
| 120 | MP0005193_abnormal_anterior_eye | 0.52132932 |
| 121 | MP0003329_amyloid_beta_deposits | 0.48889452 |
| 122 | MP0005164_abnormal_response_to | 0.48266229 |
| 123 | MP0005623_abnormal_meninges_morphology | 0.48107115 |
| 124 | MP0008789_abnormal_olfactory_epithelium | 0.47135781 |
| 125 | MP0005058_abnormal_lysosome_morphology | 0.46437251 |
| 126 | MP0001915_intracranial_hemorrhage | 0.45815730 |
| 127 | MP0000013_abnormal_adipose_tissue | 0.44773240 |
| 128 | MP0006138_congestive_heart_failure | 0.42555971 |
| 129 | MP0005375_adipose_tissue_phenotype | 0.42116104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.81730567 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.23122296 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.17152676 |
| 4 | Xanthomatosis (HP:0000991) | 5.08154097 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.42471275 |
| 6 | Ridged nail (HP:0001807) | 4.32954790 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.30589018 |
| 8 | Onycholysis (HP:0001806) | 4.24819456 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.05637321 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.04369645 |
| 11 | Atrophic scars (HP:0001075) | 3.93502600 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 3.71191452 |
| 13 | Fragile nails (HP:0001808) | 3.70604083 |
| 14 | Epidermoid cyst (HP:0200040) | 3.65022923 |
| 15 | Complement deficiency (HP:0004431) | 3.60561423 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.58731193 |
| 17 | Plantar hyperkeratosis (HP:0007556) | 3.49510128 |
| 18 | Milia (HP:0001056) | 3.46102227 |
| 19 | Protrusio acetabuli (HP:0003179) | 3.45288887 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.45238548 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.44480777 |
| 22 | Hypoplasia of dental enamel (HP:0006297) | 3.26873399 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.25185764 |
| 24 | Pterygium (HP:0001059) | 3.24781714 |
| 25 | Alopecia of scalp (HP:0002293) | 3.13510711 |
| 26 | Premature rupture of membranes (HP:0001788) | 3.13347090 |
| 27 | Selective tooth agenesis (HP:0001592) | 3.12744750 |
| 28 | Sparse eyelashes (HP:0000653) | 3.11682957 |
| 29 | Myocardial infarction (HP:0001658) | 3.08817031 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.07333686 |
| 31 | Abnormality of complement system (HP:0005339) | 3.03738502 |
| 32 | Joint hemorrhage (HP:0005261) | 2.99593297 |
| 33 | Peritonitis (HP:0002586) | 2.96885456 |
| 34 | Woolly hair (HP:0002224) | 2.92849255 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.89373829 |
| 36 | Vascular calcification (HP:0004934) | 2.86460643 |
| 37 | Fat malabsorption (HP:0002630) | 2.85231899 |
| 38 | Hypotrichosis (HP:0001006) | 2.81782436 |
| 39 | Sparse scalp hair (HP:0002209) | 2.75121865 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.71809632 |
| 41 | Oral leukoplakia (HP:0002745) | 2.70847663 |
| 42 | Lip pit (HP:0100267) | 2.69976840 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 2.69749661 |
| 44 | Hyperammonemia (HP:0001987) | 2.69314656 |
| 45 | Absent eyelashes (HP:0000561) | 2.68294408 |
| 46 | Ankyloglossia (HP:0010296) | 2.61366567 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.59126665 |
| 48 | Abnormality of nail color (HP:0100643) | 2.58038273 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.57317216 |
| 50 | Dry hair (HP:0011359) | 2.55988881 |
| 51 | Palmoplantar hyperkeratosis (HP:0000972) | 2.50638108 |
| 52 | Abnormality of the axillary hair (HP:0100134) | 2.50509891 |
| 53 | Abnormality of secondary sexual hair (HP:0009888) | 2.50509891 |
| 54 | Abnormality of the salivary glands (HP:0010286) | 2.49127121 |
| 55 | Abnormality of methionine metabolism (HP:0010901) | 2.48686702 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.48302841 |
| 57 | Nail dystrophy (HP:0008404) | 2.46829504 |
| 58 | Erythema (HP:0010783) | 2.46290048 |
| 59 | Esophageal varix (HP:0002040) | 2.45258251 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.43115331 |
| 61 | Corneal erosion (HP:0200020) | 2.38647157 |
| 62 | Popliteal pterygium (HP:0009756) | 2.36921730 |
| 63 | Thick nail (HP:0001805) | 2.36806198 |
| 64 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.33138822 |
| 65 | Flat acetabular roof (HP:0003180) | 2.32522849 |
| 66 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.31628906 |
| 67 | Palmar hyperkeratosis (HP:0010765) | 2.30352677 |
| 68 | Fragile skin (HP:0001030) | 2.27179323 |
| 69 | Anonychia (HP:0001798) | 2.25807868 |
| 70 | Spastic diplegia (HP:0001264) | 2.22622658 |
| 71 | Aplasia cutis congenita (HP:0001057) | 2.22246672 |
| 72 | Pili torti (HP:0003777) | 2.19700276 |
| 73 | Abnormal cartilage morphology (HP:0002763) | 2.18345513 |
| 74 | Abnormality of the Achilles tendon (HP:0005109) | 2.17537775 |
| 75 | Short nail (HP:0001799) | 2.16009508 |
| 76 | Abnormality of oral frenula (HP:0000190) | 2.14846399 |
| 77 | Follicular hyperkeratosis (HP:0007502) | 2.14138307 |
| 78 | Skin nodule (HP:0200036) | 2.13010880 |
| 79 | Steatorrhea (HP:0002570) | 2.12445515 |
| 80 | Malnutrition (HP:0004395) | 2.11788255 |
| 81 | Mitral stenosis (HP:0001718) | 2.11486971 |
| 82 | Palmoplantar keratoderma (HP:0000982) | 2.09757191 |
| 83 | Oligodontia (HP:0000677) | 2.09531162 |
| 84 | Hypoplastic labia majora (HP:0000059) | 2.08446361 |
| 85 | Blepharitis (HP:0000498) | 2.07988653 |
| 86 | Amniotic constriction ring (HP:0009775) | 2.07005863 |
| 87 | Abnormality of placental membranes (HP:0011409) | 2.07005863 |
| 88 | Abnormal blistering of the skin (HP:0008066) | 2.06863979 |
| 89 | Hyperglycinemia (HP:0002154) | 2.06206136 |
| 90 | Hypoglycemic coma (HP:0001325) | 2.02671309 |
| 91 | Abnormality of nucleobase metabolism (HP:0010932) | 2.02089559 |
| 92 | Ketosis (HP:0001946) | 2.01550657 |
| 93 | Amyloidosis (HP:0011034) | 1.98220667 |
| 94 | Conjugated hyperbilirubinemia (HP:0002908) | 1.97699210 |
| 95 | Spontaneous abortion (HP:0005268) | 1.96829188 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.94960478 |
| 97 | Osteolytic defects of the hand bones (HP:0009699) | 1.94960478 |
| 98 | Carious teeth (HP:0000670) | 1.93274993 |
| 99 | Abnormality of carpal bone ossification (HP:0006257) | 1.90834656 |
| 100 | Abnormal hair laboratory examination (HP:0003328) | 1.90378997 |
| 101 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90307533 |
| 102 | Nephritis (HP:0000123) | 1.90077787 |
| 103 | Shallow orbits (HP:0000586) | 1.89949478 |
| 104 | Acanthosis nigricans (HP:0000956) | 1.89314471 |
| 105 | Hypodontia (HP:0000668) | 1.87045719 |
| 106 | Hyperglycinuria (HP:0003108) | 1.86980555 |
| 107 | Increased connective tissue (HP:0009025) | 1.86636430 |
| 108 | Abnormality of purine metabolism (HP:0004352) | 1.86564927 |
| 109 | Ectopia lentis (HP:0001083) | 1.86043501 |
| 110 | Abnormality of glycine metabolism (HP:0010895) | 1.85882422 |
| 111 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.85882422 |
| 112 | Abnormality of the gastric mucosa (HP:0004295) | 1.84482982 |
| 113 | Abnormal hemoglobin (HP:0011902) | 1.84449059 |
| 114 | Hyperhidrosis (HP:0000975) | 1.83765425 |
| 115 | Cervical subluxation (HP:0003308) | 1.83764304 |
| 116 | Increased mean platelet volume (HP:0011877) | 1.83618110 |
| 117 | Abnormality of the labia majora (HP:0012881) | 1.82518539 |
| 118 | Back pain (HP:0003418) | 1.81907278 |
| 119 | Abnormal delivery (HP:0001787) | 1.81210590 |
| 120 | Arterial tortuosity (HP:0005116) | 1.80982007 |
| 121 | Hemorrhage of the eye (HP:0011885) | 1.80766521 |
| 122 | Neonatal onset (HP:0003623) | 1.80468141 |
| 123 | Mitral valve prolapse (HP:0001634) | 1.80307640 |
| 124 | Neonatal death (HP:0003811) | 1.79812291 |
| 125 | Septate vagina (HP:0001153) | 1.79697331 |
| 126 | Erythroderma (HP:0001019) | 1.79486680 |
| 127 | Turricephaly (HP:0000262) | 1.79408034 |
| 128 | Ankle contracture (HP:0006466) | 1.79346217 |
| 129 | Gout (HP:0001997) | 1.78995424 |
| 130 | Ectropion (HP:0000656) | 1.78970409 |
| 131 | Fatigable weakness (HP:0003473) | 1.76933222 |
| 132 | Abnormality of the neuromuscular junction (HP:0003398) | 1.76933222 |
| 133 | Breast hypoplasia (HP:0003187) | 1.76036458 |
| 134 | Nasolacrimal duct obstruction (HP:0000579) | 1.75662476 |
| 135 | Ulnar bowing (HP:0003031) | 1.75318577 |
| 136 | Systemic lupus erythematosus (HP:0002725) | 1.75307266 |
| 137 | Broad face (HP:0000283) | 1.74220698 |
| 138 | Abnormality of proline metabolism (HP:0010907) | 1.74153691 |
| 139 | Hydroxyprolinuria (HP:0003080) | 1.74153691 |
| 140 | Glomerulonephritis (HP:0000099) | 1.74063626 |
| 141 | Focal segmental glomerulosclerosis (HP:0000097) | 1.73771260 |
| 142 | Rickets (HP:0002748) | 1.73518338 |
| 143 | Pustule (HP:0200039) | 1.73510494 |
| 144 | Hyperbilirubinemia (HP:0002904) | 1.72266825 |
| 145 | Achilles tendon contracture (HP:0001771) | 1.71749108 |
| 146 | Natal tooth (HP:0000695) | 1.71702985 |
| 147 | Respiratory distress (HP:0002098) | 1.70482035 |
| 148 | Dehydration (HP:0001944) | 1.70412350 |
| 149 | Amelogenesis imperfecta (HP:0000705) | 1.70069436 |
| 150 | Advanced eruption of teeth (HP:0006288) | 1.69587073 |
| 151 | Menorrhagia (HP:0000132) | 1.69260596 |
| 152 | Trismus (HP:0000211) | 1.68386709 |
| 153 | Abnormality of the fingernails (HP:0001231) | 1.67432560 |
| 154 | Abnormality of permanent molar morphology (HP:0011071) | 1.65893718 |
| 155 | Abnormality of the dental root (HP:0006486) | 1.65893718 |
| 156 | Taurodontia (HP:0000679) | 1.65893718 |
| 157 | Laryngomalacia (HP:0001601) | 1.62769181 |
| 158 | Abnormal ossification of hand bones (HP:0005921) | 1.62281914 |
| 159 | Neurofibrillary tangles (HP:0002185) | 1.57146058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.22136645 |
| 2 | EPHA2 | 3.78661367 |
| 3 | MST1R | 3.23775569 |
| 4 | LATS1 | 3.10079002 |
| 5 | TRIB3 | 3.06407887 |
| 6 | FGFR4 | 2.76184653 |
| 7 | SIK1 | 2.61457063 |
| 8 | ARAF | 2.60006325 |
| 9 | PKN2 | 2.55447724 |
| 10 | EPHB2 | 2.45897928 |
| 11 | MAP3K3 | 2.22014698 |
| 12 | FER | 2.19716637 |
| 13 | PTK6 | 2.09941636 |
| 14 | NTRK1 | 2.07176022 |
| 15 | BCKDK | 1.99795914 |
| 16 | LMTK2 | 1.97059691 |
| 17 | FRK | 1.86934383 |
| 18 | SMG1 | 1.85188801 |
| 19 | LRRK2 | 1.81494611 |
| 20 | IRAK3 | 1.78737622 |
| 21 | MET | 1.78611686 |
| 22 | LATS2 | 1.74853015 |
| 23 | DDR2 | 1.66158700 |
| 24 | RIPK1 | 1.63501370 |
| 25 | MAPKAPK3 | 1.57952706 |
| 26 | PDGFRA | 1.57503024 |
| 27 | TTN | 1.55102055 |
| 28 | NEK9 | 1.52013018 |
| 29 | PTK2 | 1.51354690 |
| 30 | ERBB4 | 1.48949022 |
| 31 | EPHA3 | 1.44460941 |
| 32 | RPS6KA4 | 1.42275623 |
| 33 | EPHB1 | 1.42043231 |
| 34 | FLT3 | 1.41489189 |
| 35 | CDK6 | 1.37332606 |
| 36 | MAP3K9 | 1.34978243 |
| 37 | FGFR2 | 1.31650902 |
| 38 | ICK | 1.28311486 |
| 39 | STK10 | 1.24421922 |
| 40 | PIK3CG | 1.21097209 |
| 41 | TRPM7 | 1.20814564 |
| 42 | MAP3K10 | 1.20396013 |
| 43 | TYK2 | 1.20208961 |
| 44 | RPS6KB2 | 1.19864974 |
| 45 | CDK12 | 1.19281666 |
| 46 | STK3 | 1.18897188 |
| 47 | PAK4 | 1.18765494 |
| 48 | TBK1 | 1.18402253 |
| 49 | TGFBR2 | 1.17122166 |
| 50 | BMX | 1.16344020 |
| 51 | MAP3K6 | 1.15723690 |
| 52 | MAP3K2 | 1.13033881 |
| 53 | MST4 | 1.09343379 |
| 54 | STK38L | 1.08533599 |
| 55 | TESK1 | 1.06821080 |
| 56 | MAP2K2 | 1.01344387 |
| 57 | ERBB2 | 0.99677964 |
| 58 | EEF2K | 0.97467146 |
| 59 | PRPF4B | 0.96689327 |
| 60 | ABL2 | 0.95719019 |
| 61 | MAP2K1 | 0.95162905 |
| 62 | TAOK3 | 0.90670837 |
| 63 | MAP2K3 | 0.89836068 |
| 64 | MAP3K11 | 0.84635028 |
| 65 | MAP3K12 | 0.83757597 |
| 66 | FGFR1 | 0.83422862 |
| 67 | NME2 | 0.81892901 |
| 68 | DYRK1B | 0.81473838 |
| 69 | BRAF | 0.79441664 |
| 70 | FGFR3 | 0.77643294 |
| 71 | PAK2 | 0.75975682 |
| 72 | RPS6KA2 | 0.75884215 |
| 73 | PIM2 | 0.75645367 |
| 74 | PRKCI | 0.73591707 |
| 75 | MAPK11 | 0.73238209 |
| 76 | PBK | 0.70452327 |
| 77 | TGFBR1 | 0.69316278 |
| 78 | STK38 | 0.68551751 |
| 79 | MAP3K8 | 0.65914544 |
| 80 | PDGFRB | 0.65034864 |
| 81 | PRKD2 | 0.61351064 |
| 82 | MAP3K14 | 0.60786313 |
| 83 | GSK3A | 0.59809732 |
| 84 | STK24 | 0.57849416 |
| 85 | ERBB3 | 0.57486229 |
| 86 | MTOR | 0.57053526 |
| 87 | SCYL2 | 0.54415101 |
| 88 | MYLK | 0.54388514 |
| 89 | KDR | 0.53951515 |
| 90 | JAK1 | 0.53707099 |
| 91 | CDC42BPA | 0.52810457 |
| 92 | MAP3K1 | 0.51656458 |
| 93 | LIMK1 | 0.51455233 |
| 94 | TAOK1 | 0.49621779 |
| 95 | CHUK | 0.48780148 |
| 96 | ROCK2 | 0.48760431 |
| 97 | CSK | 0.47034025 |
| 98 | MOS | 0.44537548 |
| 99 | JAK2 | 0.44511364 |
| 100 | PRKG2 | 0.43173972 |
| 101 | MAP3K7 | 0.43011432 |
| 102 | PAK3 | 0.42388292 |
| 103 | RAF1 | 0.41094039 |
| 104 | MAP3K13 | 0.40188852 |
| 105 | EGFR | 0.40158968 |
| 106 | PRKD1 | 0.39750920 |
| 107 | IKBKE | 0.39417592 |
| 108 | ABL1 | 0.37893852 |
| 109 | MATK | 0.37503471 |
| 110 | RET | 0.37141473 |
| 111 | ILK | 0.36793041 |
| 112 | KSR2 | 0.31480833 |
| 113 | MAPKAPK2 | 0.31086361 |
| 114 | JAK3 | 0.30810393 |
| 115 | KIT | 0.30430087 |
| 116 | IGF1R | 0.30269438 |
| 117 | CAMK2G | 0.28536596 |
| 118 | PDPK1 | 0.28325543 |
| 119 | PIK3CA | 0.28112105 |
| 120 | RPS6KL1 | 0.27447387 |
| 121 | RPS6KC1 | 0.27447387 |
| 122 | ROCK1 | 0.26952743 |
| 123 | ZAP70 | 0.26609009 |
| 124 | CSF1R | 0.26096681 |
| 125 | TAOK2 | 0.25943817 |
| 126 | MAPK15 | 0.25789722 |
| 127 | CDK7 | 0.24816828 |
| 128 | SRC | 0.24283910 |
| 129 | NEK6 | 0.22034885 |
| 130 | NEK1 | 0.21632367 |
| 131 | RPS6KA1 | 0.19071258 |
| 132 | RPS6KB1 | 0.18245250 |
| 133 | AKT2 | 0.16684016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.00368431 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44920303 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.14000698 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84452891 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79609480 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.78413843 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.39118329 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.33539412 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.32601481 |
| 10 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.30566854 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30036766 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28695592 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14307390 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04689725 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04033711 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03765472 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98125298 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90140943 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.85319957 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.83595483 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83388293 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72627568 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70930769 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.69600888 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57220387 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51430748 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.50418487 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.50293975 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39929065 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35096098 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.34169166 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.32132354 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.29310778 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28585951 |
| 35 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.24061020 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22455170 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19927554 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19247006 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18386277 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.18155620 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17473167 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16824800 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14183645 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12026306 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11082369 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08763759 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06392723 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05254671 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.04635716 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.00641409 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96803785 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96147908 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.94420370 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91836156 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.91444881 |
| 56 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91408805 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87424917 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.86648047 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86474061 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83603623 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83487521 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83368806 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79053113 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76710533 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76633011 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75219068 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.74272077 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70264376 |
| 69 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68683858 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65757982 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.64951345 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64511721 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64270338 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63559324 |
| 75 | Axon guidance_Homo sapiens_hsa04360 | 0.62660920 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.62259423 |
| 77 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61748800 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61733916 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.61397675 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60679817 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59896127 |
| 82 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59381169 |
| 83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59089008 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56720530 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55084831 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55050869 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54355787 |
| 88 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53011351 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52531736 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52410988 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52064858 |
| 92 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47286983 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47178698 |
| 94 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46727382 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44957605 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43945163 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.42556062 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.42296581 |
| 99 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.40272586 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39803814 |
| 101 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36071746 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.35029948 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34097977 |
| 104 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.31971812 |
| 105 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.30488501 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29929659 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.29118699 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.28062000 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27324452 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.26084846 |
| 111 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24120510 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23943209 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.23703077 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23630614 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23293919 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.23224470 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.22955174 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21876796 |
| 119 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.21841527 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.20438710 |
| 121 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.20397942 |
| 122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19486884 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.17742729 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.17558215 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.13967322 |

